Northern Trust
ALXA

Northern Trust’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Northern Trust’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,764
Closed -$13K – 4312
2016
Q1 		$13K Hold
27,764
– – ﹤0.01% 4163
2015
Q4 		$19K Hold
27,764
– – ﹤0.01% 4178
2015
Q3 		$34K Buy
27,764
+2,603
+10% +$3.04K ﹤0.01% 4138
2015
Q2 		$27K Sell
25,161
-4,193
-14% -$6.29K ﹤0.01% 4122
2015
Q1 		$61K Sell
29,354
-133
-0.5% -$273 ﹤0.01% 4129
2014
Q4 		$44K Hold
29,487
– – ﹤0.01% 4110
2014
Q3 		$68K Sell
29,487
-1,685
-5% -$6.43K ﹤0.01% 4099
2014
Q2 		$142K Sell
31,172
-26
-0.1% -$112 ﹤0.01% 3935
2014
Q1 		$138K Sell
31,198
-971
-3% -$4.98K ﹤0.01% 3878
2013
Q4 		$152K Buy
32,169
+4,182
+15% +$20.5K ﹤0.01% 3781
2013
Q3 		$144K Buy
27,987
+428
+2% +$2.01K ﹤0.01% 3738
2013
Q2 		$120K Buy
+27,559
New +$125K ﹤0.01% 3775

Northern Trust's ALXA Position: Q2 2016 in Review

Northern Trust sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 27,764 shares — an estimated $13K sold.

Northern Trust first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $152K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Northern Trust reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Northern Trust sold 27,764 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $13K.
  • Northern Trust first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Northern Trust's Alexza Pharmaceuticals Inc position peaked at $152K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Northern Trust's 13F filing for Q2 2016, filed 12 Aug 2016.